Sphingolipids in atherosclerosis: a metabolic underpinning of vascular disease

Author： Rekhter Mark   Karathanasis Sotirios  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.5, 2006-10, pp. : 605-614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease

By Jover Eva  

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 274-290

Informa Healthcare

Access to resources Recommend Favorite

Vascular Disease in the Metabolic Syndrome: Do We Need to Target the Microcirculation to Treat Large Vessel Disease?

By  

Journal of Vascular Research, Vol. 46, Iss. 6, 2009-06 ,pp. : 515-526

Karger

Access to resources Recommend Favorite

Transglutaminases in Vascular Biology: Relevance for Vascular Remodeling and Atherosclerosis

By  

Journal of Vascular Research, Vol. 45, Iss. 4, 2008-01 ,pp. : 271-278

Karger

Access to resources Recommend Favorite

DNA damage, vascular senescence and atherosclerosis

By Andreassi Maria  

Journal of Molecular Medicine, Vol. 86, Iss. 9, 2008-09 ,pp. : 1033-1043

Springer Publishing Company

Access to resources Recommend Favorite

Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease

By  

PATHOLOGY INTERNATIONAL, Vol. 68, Iss. 2, 2018-02 ,pp. : 91-101

John Wiley & Sons Inc

Access to resources Recommend Favorite